Succinic Semialdehyde Dehydrogenase Deficiency: In Vitro and In Silico Characterization of a Novel Pathogenic Missense Variant and Analysis of the Mutational Spectrum of <i>ALDH5A1</i>

Succinic semialdehyde dehydrogenase deficiency (SSADHD) is a rare, monogenic disorder affecting the degradation of the main inhibitory neurotransmitter γ-amino butyric acid (GABA). Pathogenic variants in the <i>ALDH5A1</i> gene that cause an enzymatic dysfunction of succinic semialdehyde...

Full description

Bibliographic Details
Main Authors: Heiko Brennenstuhl, Miroslava Didiasova, Birgit Assmann, Mariarita Bertoldi, Gianluca Molla, Sabine Jung-Klawitter, Oya Kuseyri Hübschmann, Julian Schröter, Thomas Opladen, Ritva Tikkanen
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/22/8578
id doaj-b42e97c8a9b2402793f8694b5b45732f
record_format Article
spelling doaj-b42e97c8a9b2402793f8694b5b45732f2020-11-25T04:09:44ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-11-01218578857810.3390/ijms21228578Succinic Semialdehyde Dehydrogenase Deficiency: In Vitro and In Silico Characterization of a Novel Pathogenic Missense Variant and Analysis of the Mutational Spectrum of <i>ALDH5A1</i>Heiko Brennenstuhl0Miroslava Didiasova1Birgit Assmann2Mariarita Bertoldi3Gianluca Molla4Sabine Jung-Klawitter5Oya Kuseyri Hübschmann6Julian Schröter7Thomas Opladen8Ritva Tikkanen9Department of General Pediatrics, Division of Neuropediatrics and Metabolic Medicine, University Children’s Hospital Heidelberg, 69120 Heidelberg, GermanyInstitute of Biochemistry, Medical Faculty, University of Giessen, 35392 Giessen, GermanyDepartment of General Pediatrics, Division of Neuropediatrics and Metabolic Medicine, University Children’s Hospital Heidelberg, 69120 Heidelberg, GermanyDepartment of Neuroscience, Biomedicine and Movement, Section of Biological Chemistry, University of Verona, Strada Le Grazie, 8, 37134 Verona, ItalyDepartment of Biotechnology and Life Sciences, University of Insubria, via J.H. Dunant 3, 21100 Varese, ItalyDepartment of General Pediatrics, Division of Neuropediatrics and Metabolic Medicine, University Children’s Hospital Heidelberg, 69120 Heidelberg, GermanyDepartment of General Pediatrics, Division of Neuropediatrics and Metabolic Medicine, University Children’s Hospital Heidelberg, 69120 Heidelberg, GermanyDepartment of General Pediatrics, Division of Neuropediatrics and Metabolic Medicine, University Children’s Hospital Heidelberg, 69120 Heidelberg, GermanyDepartment of General Pediatrics, Division of Neuropediatrics and Metabolic Medicine, University Children’s Hospital Heidelberg, 69120 Heidelberg, GermanyInstitute of Biochemistry, Medical Faculty, University of Giessen, 35392 Giessen, GermanySuccinic semialdehyde dehydrogenase deficiency (SSADHD) is a rare, monogenic disorder affecting the degradation of the main inhibitory neurotransmitter γ-amino butyric acid (GABA). Pathogenic variants in the <i>ALDH5A1</i> gene that cause an enzymatic dysfunction of succinic semialdehyde dehydrogenase (SSADH) lead to an accumulation of potentially toxic metabolites, including γ–hydroxybutyrate (GHB). Here, we present a patient with a severe phenotype of SSADHD caused by a novel genetic variant c.728T > C that leads to an exchange of leucine to proline at residue 243, located within the highly conserved nicotinamide adenine dinucleotide (NAD)<sup>+</sup> binding domain of SSADH. Proline harbors a pyrrolidine within its side chain known for its conformational rigidity and disruption of protein secondary structures. We investigate the effect of this novel variant in vivo, in vitro, and in silico. We furthermore examine the mutational spectrum of all previously described disease-causing variants and computationally assess all biologically possible missense variants of <i>ALDH5A1</i> to identify mutational hotspots.https://www.mdpi.com/1422-0067/21/22/8578inherited metabolic diseasesuccinic semialdehyde dehydrogenase deficiencyγ-amino butyric acidγ–hydroxybutyratemutational spectrum
collection DOAJ
language English
format Article
sources DOAJ
author Heiko Brennenstuhl
Miroslava Didiasova
Birgit Assmann
Mariarita Bertoldi
Gianluca Molla
Sabine Jung-Klawitter
Oya Kuseyri Hübschmann
Julian Schröter
Thomas Opladen
Ritva Tikkanen
spellingShingle Heiko Brennenstuhl
Miroslava Didiasova
Birgit Assmann
Mariarita Bertoldi
Gianluca Molla
Sabine Jung-Klawitter
Oya Kuseyri Hübschmann
Julian Schröter
Thomas Opladen
Ritva Tikkanen
Succinic Semialdehyde Dehydrogenase Deficiency: In Vitro and In Silico Characterization of a Novel Pathogenic Missense Variant and Analysis of the Mutational Spectrum of <i>ALDH5A1</i>
International Journal of Molecular Sciences
inherited metabolic disease
succinic semialdehyde dehydrogenase deficiency
γ-amino butyric acid
γ–hydroxybutyrate
mutational spectrum
author_facet Heiko Brennenstuhl
Miroslava Didiasova
Birgit Assmann
Mariarita Bertoldi
Gianluca Molla
Sabine Jung-Klawitter
Oya Kuseyri Hübschmann
Julian Schröter
Thomas Opladen
Ritva Tikkanen
author_sort Heiko Brennenstuhl
title Succinic Semialdehyde Dehydrogenase Deficiency: In Vitro and In Silico Characterization of a Novel Pathogenic Missense Variant and Analysis of the Mutational Spectrum of <i>ALDH5A1</i>
title_short Succinic Semialdehyde Dehydrogenase Deficiency: In Vitro and In Silico Characterization of a Novel Pathogenic Missense Variant and Analysis of the Mutational Spectrum of <i>ALDH5A1</i>
title_full Succinic Semialdehyde Dehydrogenase Deficiency: In Vitro and In Silico Characterization of a Novel Pathogenic Missense Variant and Analysis of the Mutational Spectrum of <i>ALDH5A1</i>
title_fullStr Succinic Semialdehyde Dehydrogenase Deficiency: In Vitro and In Silico Characterization of a Novel Pathogenic Missense Variant and Analysis of the Mutational Spectrum of <i>ALDH5A1</i>
title_full_unstemmed Succinic Semialdehyde Dehydrogenase Deficiency: In Vitro and In Silico Characterization of a Novel Pathogenic Missense Variant and Analysis of the Mutational Spectrum of <i>ALDH5A1</i>
title_sort succinic semialdehyde dehydrogenase deficiency: in vitro and in silico characterization of a novel pathogenic missense variant and analysis of the mutational spectrum of <i>aldh5a1</i>
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2020-11-01
description Succinic semialdehyde dehydrogenase deficiency (SSADHD) is a rare, monogenic disorder affecting the degradation of the main inhibitory neurotransmitter γ-amino butyric acid (GABA). Pathogenic variants in the <i>ALDH5A1</i> gene that cause an enzymatic dysfunction of succinic semialdehyde dehydrogenase (SSADH) lead to an accumulation of potentially toxic metabolites, including γ–hydroxybutyrate (GHB). Here, we present a patient with a severe phenotype of SSADHD caused by a novel genetic variant c.728T > C that leads to an exchange of leucine to proline at residue 243, located within the highly conserved nicotinamide adenine dinucleotide (NAD)<sup>+</sup> binding domain of SSADH. Proline harbors a pyrrolidine within its side chain known for its conformational rigidity and disruption of protein secondary structures. We investigate the effect of this novel variant in vivo, in vitro, and in silico. We furthermore examine the mutational spectrum of all previously described disease-causing variants and computationally assess all biologically possible missense variants of <i>ALDH5A1</i> to identify mutational hotspots.
topic inherited metabolic disease
succinic semialdehyde dehydrogenase deficiency
γ-amino butyric acid
γ–hydroxybutyrate
mutational spectrum
url https://www.mdpi.com/1422-0067/21/22/8578
work_keys_str_mv AT heikobrennenstuhl succinicsemialdehydedehydrogenasedeficiencyinvitroandinsilicocharacterizationofanovelpathogenicmissensevariantandanalysisofthemutationalspectrumofialdh5a1i
AT miroslavadidiasova succinicsemialdehydedehydrogenasedeficiencyinvitroandinsilicocharacterizationofanovelpathogenicmissensevariantandanalysisofthemutationalspectrumofialdh5a1i
AT birgitassmann succinicsemialdehydedehydrogenasedeficiencyinvitroandinsilicocharacterizationofanovelpathogenicmissensevariantandanalysisofthemutationalspectrumofialdh5a1i
AT mariaritabertoldi succinicsemialdehydedehydrogenasedeficiencyinvitroandinsilicocharacterizationofanovelpathogenicmissensevariantandanalysisofthemutationalspectrumofialdh5a1i
AT gianlucamolla succinicsemialdehydedehydrogenasedeficiencyinvitroandinsilicocharacterizationofanovelpathogenicmissensevariantandanalysisofthemutationalspectrumofialdh5a1i
AT sabinejungklawitter succinicsemialdehydedehydrogenasedeficiencyinvitroandinsilicocharacterizationofanovelpathogenicmissensevariantandanalysisofthemutationalspectrumofialdh5a1i
AT oyakuseyrihubschmann succinicsemialdehydedehydrogenasedeficiencyinvitroandinsilicocharacterizationofanovelpathogenicmissensevariantandanalysisofthemutationalspectrumofialdh5a1i
AT julianschroter succinicsemialdehydedehydrogenasedeficiencyinvitroandinsilicocharacterizationofanovelpathogenicmissensevariantandanalysisofthemutationalspectrumofialdh5a1i
AT thomasopladen succinicsemialdehydedehydrogenasedeficiencyinvitroandinsilicocharacterizationofanovelpathogenicmissensevariantandanalysisofthemutationalspectrumofialdh5a1i
AT ritvatikkanen succinicsemialdehydedehydrogenasedeficiencyinvitroandinsilicocharacterizationofanovelpathogenicmissensevariantandanalysisofthemutationalspectrumofialdh5a1i
_version_ 1724421979507785728